Bailard’s Nuvalent NUVL Stock Holding History

Bailard’s Portfolio NUVL Stock Details NUVL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-8,982	Closed	-$234K	–	750
2023 Q1	$234K	Hold	8,982	–	–	0.01%	590
2022 Q4	$267K	Sell	8,982 -2,700	-23%	-$75.3K	0.01%	548
2022 Q3	$227K	Buy	+11,682	New	+$196K	0.01%	543

Other funds holding NUVL

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Bailard's NUVL Position: Q2 2023 in Review

Bailard sold out of Nuvalent (NUVL) in Q2 2023, closing a stake of 8,982 shares — an estimated $234K sold.

Bailard first reported a position in NUVL in Q3 2022 and held it in 3 quarters. The position peaked at $267K in Q4 2022. 110 funds tracked by Wall St. Rank hold NUVL as of Q2 2023.

Bailard reported no remaining Nuvalent position as of Q2 2023 after selling out during the quarter.
Bailard sold 8,982 Nuvalent shares in Q2 2023, an estimated $234K.
Bailard first reported a position in Nuvalent in Q3 2022 and held it in 3 quarters.
Bailard's Nuvalent position peaked at $267K in Q4 2022.
110 funds tracked by Wall St. Rank held Nuvalent as of Q2 2023.

Based on Bailard's 13F filing for Q2 2023, filed 20 Jul 2023.